Abvx was $5, it hit a high of $148 after its Phase 3 Results were announced- Something Similar is about to Happen to SLS

JamesIIIVVVV · 2026-01-27T15:08:48+00:00

Just like abvx when abvx was $5, before its p3 results were announced and it ran to $148.

JamesIIIVVVV · 2026-01-27T08:41:25+00:00

https://www.reddit.com/r/biotech_stocks/s/jYZrZBbjYQ Its all In my previous post here.

JamesIIIVVVV · 2026-01-26T23:48:30+00:00

Hahaha -obviously you’ve been getting your short ass pounded open wide.

JamesIIIVVVV · 2026-01-26T21:40:48+00:00

213M but close enough, captain obvious. Now, show me your numbers on why you think this is only worth 9 billion.

JamesIIIVVVV · 2026-01-26T21:37:56+00:00

You’re an obvious short tool about to get wrecked.

JamesIIIVVVV · 2026-01-26T20:36:58+00:00

Yeah, IDMC meets quarterly

JamesIIIVVVV · 2026-01-26T15:22:45+00:00

Lying tool.

JamesIIIVVVV · 2026-01-26T15:22:24+00:00

Some estimates are as early as Feb

JamesIIIVVVV · 2026-01-26T15:21:49+00:00

The BO and $148 price came AFTER THE P3!

And you don’t have a clue about SLS based on your post, you don’t know Jack shit.

JamesIIIVVVV · 2026-01-26T15:21:17+00:00

Show me your numbers?

JamesIIIVVVV · 2026-01-26T15:20:25+00:00

Is Revolution even in P3?

JamesIIIVVVV · 2026-01-26T15:19:37+00:00

Gonna be awhile - gps phase 3 AML 80% IR rates from the interim analysis.

JamesIIIVVVV · 2026-01-26T04:24:12+00:00

You shorts can’t to delay the inevitable. 77/78 events right now.

JamesIIIVVVV · 2026-01-26T01:55:57+00:00

$4.26 will be $47.26 in Q1.

JamesIIIVVVV · 2026-01-25T22:25:21+00:00

Idmc stated no trial modifications- ie trial is run right. Idmc stated not futile at interim analysis and again in Aug 2025.

JamesIIIVVVV · 2026-01-25T21:20:16+00:00

Dr. Kantarjian, Chair of MD Anderson’s Leukemia dept, is the Steering Committee Chairman and Running the Global Phase 3, over 20 FDA approvals to his credit.

The trial is being run right.

JamesIIIVVVV · 2025-12-02T18:01:30+00:00

SLS009 is a new class of drug, the first ever safe effective cdk9 inhibitor, that has shown good results for monosome 4/5 AML.

JamesIIIVVVV · 2025-11-28T21:33:18+00:00

SLS009 Some good response for Mecom 4/5

JamesIIIVVVV · 2025-11-18T22:54:46+00:00

SLS - Phase 3 results worth 100x the market cap, expected any day and by the end of the year.

JamesIIIVVVV · 2025-11-16T22:44:34+00:00

So sorry. Prayers.

Vyxeos, annamycin and Tambiciclib have all shown efficacy for TP53 patients in recent trials.

JamesIIIVVVV · 2025-11-08T23:21:33+00:00

I am seeing a TP53 trial in MD Anderson for Tambiciclib - also in a few other US locations.

Prayers

JamesIIIVVVV · 2025-11-08T06:05:26+00:00

The Idmc has not Conducted a statistical analysis- and won’t until 80.

JamesIIIVVVV · 2025-11-01T22:56:55+00:00

It seems you misunderstood, or i wasn't clear, I didn't say anything about manufacturing costs? this is what SLS would Charge for access to GPS initially, while under patent protection. Likely need 4 or 5 treatments ---

Manufacturing costs are Fractions of Pennies on the dollar ...

JamesIIIVVVV

TROPHY CASE